Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aleksandra Marchwicka

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
International Journal of Molecular Sciences|July 4, 2018
Regulation of Expression of CEBP Genes by Variably Expressed Vitamin D Receptor and Retinoic Acid Receptor α in Human Acute Myeloid Leukemia Cell LinesAleksandra Marchwicka, Ewa Marcinkowska
Advances in Food and Nutrition Research|May 22, 2024
Vitamin D and immune systemGeoffrey Brown, Aleksandra Marchwicka, Ewa Marcinkowska
Cell & Bioscience|February 4, 2016
Restored expression of vitamin D receptor and sensitivity to 1,25-dihydroxyvitamin D3 in response to disrupted fusion FOP2-FGFR1 gene in acute myeloid leukemia cellsAleksandra Marchwicka, Aoife Corcoran, Klaudia Berkowska, et al.
Leukemia Research and Treatment|December 6, 2012
Regulation of Leukemic Cell Differentiation through the Vitamin D Receptor at the Levels of Intracellular Signal Transduction, Gene Transcription, and Protein Trafficking and StabilityElżbieta Gocek, Hanna Baurska, Aleksandra Marchwicka, et al.
Plos One|March 20, 2014
NADPH-cytochrome P450 reductase is regulated by all-trans retinoic acid and by 1,25-dihydroxyvitamin D3 in human acute myeloid leukemia cellsElżbieta Gocek, Aleksandra Marchwicka, Kamila Bujko, et al.
Expert Opinion on Therapeutic Patents|June 24, 2016
Therapeutic use of selective synthetic ligands for retinoic acid receptors: a patent reviewAleksandra Marchwicka, Alan Cunningham, Ewa Marcinkowska, et al.
Chemmedchem|March 3, 2018
Synthesis and Biological Evaluation of Imidazole-Bearing α-Phosphonocarboxylates as Inhibitors of Rab Geranylgeranyl Transferase (RGGT)Łukasz Joachimiak, Aleksandra Marchwicka, Edyta Gendaszewska-Darmach, et al.
Frontiers in Oncology|June 7, 2014
Perspectives of differentiation therapies of acute myeloid leukemia: the search for the molecular basis of patients' variable responses to 1,25-dihydroxyvitamin d and vitamin d analogsAleksandra Marchwicka, Małgorzata Cebrat, Preetha Sampath, et al.
Oncology Reports|July 4, 2012
Studies on the mechanisms of superagonistic pro-differentiating activities of side-chain modified analogs of vitamin D2Hanna Baurska, Aleksandra Marchwicka, Anna Kłopot, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 14, 2012
Opposite regulation of vitamin D receptor by ATRA in AML cells susceptible and resistant to vitamin D-induced differentiationElżbieta Gocek, Aleksandra Marchwicka, Hanna Baurska, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
International Journal of Molecular Sciences|July 4, 2018
Regulation of Expression of CEBP Genes by Variably Expressed Vitamin D Receptor and Retinoic Acid Receptor α in Human Acute Myeloid Leukemia Cell LinesAleksandra Marchwicka, Ewa Marcinkowska
Advances in Food and Nutrition Research|May 22, 2024
Vitamin D and immune systemGeoffrey Brown, Aleksandra Marchwicka, Ewa Marcinkowska
Cell & Bioscience|February 4, 2016
Restored expression of vitamin D receptor and sensitivity to 1,25-dihydroxyvitamin D3 in response to disrupted fusion FOP2-FGFR1 gene in acute myeloid leukemia cellsAleksandra Marchwicka, Aoife Corcoran, Klaudia Berkowska, et al.
Leukemia Research and Treatment|December 6, 2012
Regulation of Leukemic Cell Differentiation through the Vitamin D Receptor at the Levels of Intracellular Signal Transduction, Gene Transcription, and Protein Trafficking and StabilityElżbieta Gocek, Hanna Baurska, Aleksandra Marchwicka, et al.
Plos One|March 20, 2014
NADPH-cytochrome P450 reductase is regulated by all-trans retinoic acid and by 1,25-dihydroxyvitamin D3 in human acute myeloid leukemia cellsElżbieta Gocek, Aleksandra Marchwicka, Kamila Bujko, et al.
Expert Opinion on Therapeutic Patents|June 24, 2016
Therapeutic use of selective synthetic ligands for retinoic acid receptors: a patent reviewAleksandra Marchwicka, Alan Cunningham, Ewa Marcinkowska, et al.
Chemmedchem|March 3, 2018
Synthesis and Biological Evaluation of Imidazole-Bearing α-Phosphonocarboxylates as Inhibitors of Rab Geranylgeranyl Transferase (RGGT)Łukasz Joachimiak, Aleksandra Marchwicka, Edyta Gendaszewska-Darmach, et al.
Frontiers in Oncology|June 7, 2014
Perspectives of differentiation therapies of acute myeloid leukemia: the search for the molecular basis of patients' variable responses to 1,25-dihydroxyvitamin d and vitamin d analogsAleksandra Marchwicka, Małgorzata Cebrat, Preetha Sampath, et al.
Oncology Reports|July 4, 2012
Studies on the mechanisms of superagonistic pro-differentiating activities of side-chain modified analogs of vitamin D2Hanna Baurska, Aleksandra Marchwicka, Anna Kłopot, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 14, 2012
Opposite regulation of vitamin D receptor by ATRA in AML cells susceptible and resistant to vitamin D-induced differentiationElżbieta Gocek, Aleksandra Marchwicka, Hanna Baurska, et al.
Pageof 2